by Edward i. Burger, Jr.* To attempt to summarize the proceedings of a meeting such as this one in any rigorous sense is clearly an unreasonably ambitious task. It is made more challenging because of the tentative character of much of the work commented upon here.
This meeting, one of a series (and I hope a growing series) for the National Institute of Environmental Health Sciences, represents an extraordinarily useful concept. It is designed to bring together a variety of scientific bedfellows who have contemplated (and indeed investigated) a subject for its academic interest and for its very timely topical interest. These same scientists would have learned about each other eventually but, in the best tradition of science, it would have taken a long time.
By design, we are witnessing the cutting edge of scientific research for this area. This meeting has, as its avowed and very virtuous purpose, the calling out of the walls a good deal of unmatured and not totally interpreted or confirmed research. It is important to keep this tentative and unconfirmed character in mind.
One is struck, too, by the character of the research which has been reported at this meeting. There are still many gaps in our knowledge about dibenzofurans and dioxins. For example, we should somehow ascertain whether Yusho disease in Japan was a reflection of exposure to polychlorinated biphenyls or to furan impurities. Dr. FireEnvironmental Health Perspectives stone reviewed the history of the contribution of the chick edema factor to our understanding of dioxins. The sleuthing done by the FDA pieced together the story of the large-scale loss of poultry (which happened first in 1957), related it to the use of tallow in poultry feed and, eventually, to the presence of dioxin impurities. Higginbotham et al. first offered a rough approximation of ranking of biological activity of dioxins which has turned out to be strikingly accurate. What has emerged from this meeting is the very wide range of toxicity for the several members of the dioxin family (perhaps as much as 107).
This meeting revealed some interesting (and perhaps, ultimately successful) attempts to relate chemical structure to biological activity. Several participants reminded us that to be a successful toxic dioxin, a candidate needs two halogens at the 2 and 3 positions and one at the 7 position; it also needs halogens on both benezene rings. Bromine confers more biological activity than chlorine, and chlorine more than fluorine.
I'll say very little about teratogenesis. It seems to me that a strong case can be made for clearing the air about the mechanism of teratogenesis. Is this an example of acute (embryo) toxicity with a steep dose-response curve and a demonstrable threshold? It's not clear that everyone who reports birth defects is talking about the same phenomenon. Dr. Moore, at this meeting, described some fascinating, postnatal effects of maternal exposure to TCDD through a series of cross-fostering and reciprocal cross-fostering studies of mice. These deserve further attempts at interpretation.
The effects on experimental animals are difficult to summarize completely. However, there are some underlying currents showing through:
(1) there is a variation in susceptibility among species-guinea pigs versus rats and mice; (2) there are striking sex differences; (3) delayed effects-are very prominent (liver changes 2 weeks after exposure); (4) the major sites of toxic action appear to be the liver (seen as a variety of changes in-liver function), the hematopoietic system (platelet depression, altered platelet function, leucocytosis and hemoconcentration) and the lymphatic system (spleen, thymus and lymph nodes). The atrophy of the thymus and the general lymphoid depletion reported at this meeting were very striking.
As for morphological alterations, the changes in the ultrastructure under the electron microscope are of course most interesting. Perhaps the most significant point is that the morphological alterations tend to follow and confirm the functional changes which were described independently. There seems to be a delay (perhaps on the order of 3 days) between exposure and manifest structural changes. The magnitude of the change is dose-related, and the changes are reversible with time. A particularly fascinating finding was that of multinucleated hepatic cells. Do these represent a stage of attempted regeneration and repair? Alternatively, are they possible precursors of neoplastic change? This conference presented little evidence that dioxins would induce or promote neoplastic changes in tissues.
Patterns of absorption into the organism and of distribution among organs once absorbed are beginning to emerge. Not unexpectedly, water and lipid solubility seems to emerge as a major influence, although clearly not the only one. For tetrachlorodibenzop-dioxin (high doses in male rats), the amount absorbed via the intestine from an ingested dose appears to be about 70%. The majority of the absorbed dose appears in the feces at a rate of 1-2% day and in the urine at a rate of 0.5%7 day. A small amount can be detected in the expired air (<0.1% day). The material resident in the organism is characteristically found in the adipose tissue and the liver. It is notably absent from certain other fatty tissues such as those of the central nervous system. By contrast, for octachlorodibenzo-p-dioxin, only 5 % achieves absorption. Again, a large share is found in the liver (50%o) and in the adipose tissues (12%o). Once in the liver, this material apparently tends to remain resident for long periods in the liver microsomes.
This The meaning of enzyme changes is as yet unclear. There are some striking differences among species. ALA synthetase, whose activity is related to the disease, porphyria, can be induced by dioxin administration in the chick embryo but apparently not in mammals. One has the impression of being very close to some insight into mechanisms yet not close enough. The combination of enzyme induction studies and changes in cellular ultrastructure could prove very helpful.
Where do we stand on our knowledge of biological activity? For furans, we know very little. It seems to me that we still must determine whether Yusho disease was a reflection of PCB exposure or a result of exposure to dibenzofuran or other impurity. For dioxins, we now are better equipped. However, we must now reconcile a number of somewhat paradoxical observations: (1) extraordinarily high degree of biological activity, especially for certain chemical form.; (tetrachlorodibenzo-p-dioxin was pointed out to be the most potent small molecule toxin known); (2) striking species differences in activity; (3) sex differences; (4) biological activity falls off rapidly with changes in chemical structure; (5) latent period before toxic manifestations; (6) doserelated effects; (7) long-lasting but ultimately reversible effects.
Effects on Wildlife
Understandably there is less work here than one would like. The preliminary work reported by Bowes concerning survey of wildlife is a good model and should be continued. Preliminary results seemed to suggest a very wide variety of chemical species found in the animals examined with an uncertain role for dioxins and furans.
